Wells Fargo & Company Ardelyx, Inc. Transaction History

Wells Fargo & Company

$433 Billion
Q4 2024

A detailed history of Wells Fargo & Company transactions in Ardelyx, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 162,656 shares of ARDX stock, worth $743,337. This represents 0.0% of its overall portfolio holdings.

Number of Shares

162,656

Previous 323,642 49.74%

Holding current value

$743,337

Previous $2.23 Million 62.31%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	SELL	$4.49 - $6.85 $722,827 - $1.1 Million	-160,986 Reduced 49.74%	162,656 $840,000
Q3 2024 Nov 13, 2024	SELL	$5.28 - $7.57 $2.96 Million - $4.24 Million	-560,523 Reduced 63.4%	323,642 $2.23 Million
Q2 2024 Aug 13, 2024	BUY	$5.89 - $9.31 $4.52 Million - $7.15 Million	767,586 Added 658.43%	884,165 $6.55 Million
Q1 2024 May 10, 2024	BUY	$6.05 - $9.74 $62,375 - $100,419	10,310 Added 9.7%	116,579 $851,000
Q4 2023 Feb 09, 2024	SELL	$3.29 - $6.64 $589,127 - $1.19 Million	-179,066 Reduced 62.76%	106,269 $658,000
Q3 2023 Nov 13, 2023	SELL	$3.3 - $4.83 $597,890 - $875,094	-181,179 Reduced 38.84%	285,335 $1.16 Million
Q2 2023 Aug 15, 2023	BUY	$3.23 - $4.95 $581,664 - $891,405	180,082 Added 62.87%	466,514 $1.58 Million
Q1 2023 May 12, 2023	BUY	$2.68 - $4.79 $690,649 - $1.23 Million	257,705 Added 897.08%	286,432 $1.37 Million
Q4 2022 Feb 13, 2023	SELL	$1.22 - $2.85 $7,625 - $17,812	-6,250 Reduced 17.87%	28,727 $81,000
Q3 2022 Nov 14, 2022	SELL	$0.59 - $1.44 $1,969 - $4,806	-3,338 Reduced 8.71%	34,977 $41,000
Q2 2022 Aug 12, 2022	SELL	$0.51 - $1.17 $10,481 - $24,045	-20,552 Reduced 34.91%	38,315 $23,000
Q1 2022 May 16, 2022	SELL	$0.65 - $1.18 $22,570 - $40,974	-34,724 Reduced 37.1%	58,867 $63,000
Q4 2021 Feb 14, 2022	SELL	$0.86 - $1.7 $16,028 - $31,684	-18,638 Reduced 16.61%	93,591 $103,000
Q3 2021 Nov 15, 2021	BUY	$1.27 - $8.17 $138,071 - $888,226	108,718 Added 3096.5%	112,229 $148,000
Q2 2021 Aug 16, 2021	SELL	$6.55 - $8.98 $35,723 - $48,976	-5,454 Reduced 60.84%	3,511 $26,000
Q1 2021 May 13, 2021	SELL	$6.1 - $7.69 $466,570 - $588,185	-76,487 Reduced 89.51%	8,965 $59,000
Q4 2020 Feb 09, 2021	SELL	$5.05 - $7.1 $358,938 - $504,646	-71,077 Reduced 45.41%	85,452 $553,000
Q3 2020 Nov 05, 2020	BUY	$5.25 - $7.08 $9,597 - $12,942	1,828 Added 1.18%	156,529 $822,000
Q2 2020 Aug 13, 2020	BUY	$5.37 - $8.11 $605,102 - $913,851	112,682 Added 268.17%	154,701 $1.07 Million
Q1 2020 May 14, 2020	BUY	$4.35 - $8.79 $182,782 - $369,347	42,019 New	42,019 $239,000

Others Institutions Holding ARDX

# of Institutions

235

Shares Held

150M

Call Options Held

1.54M

Put Options Held

3.08M

View Full List

About ARDELYX, INC.

Ticker ARDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 154,636,000
Market Cap $707M
Description
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...

More about ARDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Ardelyx, Inc. Transaction History